Katherine Amato

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling

Juliann Chmielecki, Jasmine Foo, Geoffrey R. Oxnard et al. · Science Translational Medicine · 2011 · 524 citations

Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC

Katherine Amato, Shan Wang, Andrew K. Hastings et al. · Journal of Clinical Investigation · 2014 · 122 citations · Full text

Apoptosis, Immunology, Pathology +17

EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer

Katherine Amato, Shan Wang, Li Tan et al. · Cancer Research · 2016 · 115 citations · Full text

Lung Tumors, Fda-approved Therapies, Medicine +13

Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer

Guanglei Zhuang, Wenqiang Song, Katherine Amato et al. · JNCI Journal of the National Cancer Institute · 2012 · 74 citations · Full text